Cold Autoimmune Hemolytic Anemia due to High-grade non Hodgkin's B cell Lymphoma with Weak Response to Rituximab and Chemotherapy Regimens

Autoimmune hemolytic anemia (AIHA) is characterized by shortening of red blood cell (RBC) survival and the presence of autoantibodies directed against autologous RBCs. Approximately 20% of autoimmune hemolytic anemia cases are associated with cold-reactive antibody. About half of patients with AIHA...

Descripción completa

Detalles Bibliográficos
Autores principales: Nazel Khosroshahi, Behzad, Jafari, Mohammad, Vazini, Hossein, Ahmadi, Alireza, Shams, Keivan, Kholoujini, Mahdi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Tehran University of Medical Sciences, Hematology-Oncology and Stem Cell Transplantation Research Center 2015
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4529683/
https://www.ncbi.nlm.nih.gov/pubmed/26261701

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4529683/
https://www.ncbi.nlm.nih.gov/pubmed/26261701

Ejemplares similares